162 related articles for article (PubMed ID: 36532023)
1. ADAR1 promotes systemic sclerosis
Sun C; Cai D; Chen SY
Front Immunol; 2022; 13():1051254. PubMed ID: 36532023
[TBL] [Abstract][Full Text] [Related]
2. RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.
Sun C; Chen SY
J Immunol; 2018 Apr; 200(8):2777-2785. PubMed ID: 29507108
[TBL] [Abstract][Full Text] [Related]
3. ADAR1 Non-Editing Function in Macrophage Activation and Abdominal Aortic Aneurysm.
Cai D; Sun C; Murashita T; Que X; Chen SY
Circ Res; 2023 Feb; 132(4):e78-e93. PubMed ID: 36688311
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.
Vlachogiannis NI; Tual-Chalot S; Zormpas E; Bonini F; Ntouros PA; Pappa M; Bournia VK; Tektonidou MG; Souliotis VL; Mavragani CP; Stamatelopoulos K; Gatsiou A; Sfikakis PP; Stellos K
J Autoimmun; 2021 Dec; 125():102755. PubMed ID: 34857436
[TBL] [Abstract][Full Text] [Related]
5. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
[TBL] [Abstract][Full Text] [Related]
6. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
[TBL] [Abstract][Full Text] [Related]
7. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
9. ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
Garcia-Gonzalez C; Dieterich C; Maroli G; Wiesnet M; Wietelmann A; Li X; Yuan X; Graumann J; Stellos K; Kubin T; Schneider A; Braun T
Circ Res; 2022 Sep; 131(7):580-597. PubMed ID: 36000401
[TBL] [Abstract][Full Text] [Related]
10. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
11. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
12. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
[TBL] [Abstract][Full Text] [Related]
14. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
[TBL] [Abstract][Full Text] [Related]
15. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.
Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL
Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283
[TBL] [Abstract][Full Text] [Related]
16. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J
BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081
[TBL] [Abstract][Full Text] [Related]
17. ADAR1-Mediated RNA Editing, A Novel Mechanism Controlling Phenotypic Modulation of Vascular Smooth Muscle Cells.
Fei J; Cui XB; Wang JN; Dong K; Chen SY
Circ Res; 2016 Jul; 119(3):463-9. PubMed ID: 27199464
[TBL] [Abstract][Full Text] [Related]
18. IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation.
Wu X; Ming B; Wu T; Gao R; Hu P; Tang J; Zhong J; Zheng F; Dong L
J Dermatol Sci; 2022 Aug; 107(2):95-104. PubMed ID: 35940987
[TBL] [Abstract][Full Text] [Related]
19. ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis.
Ben-Shoshan SO; Kagan P; Sultan M; Barabash Z; Dor C; Jacob-Hirsch J; Harmelin A; Pappo O; Marcu-Malina V; Ben-Ari Z; Amariglio N; Rechavi G; Goldstein I; Safran M
RNA Biol; 2017 May; 14(5):587-602. PubMed ID: 27362366
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
